Curated networking among founders, investors, health system leaders, policymakers, and platformoperators. Light breakfast and facilitated introductions.

-

This panel will move beyond headline innovation to examine which healthcare and life sciencesmodels are achieving real-world adoption.

Speakers:
● Dr. Shara Nawar
● Melissa Cohen
● Carter Cliff
‍
Discussion Focus
‍
● Which AI, data, and platform models are deployable today
● How health systems evaluate traction versus promise
● Institutional barriers to scale and how they are being overcome
● Lessons from organizations already operationalizing innovation

This panel will examine how regulatory shifts, reimbursement dynamics, and risk allocation areshaping healthcare and life sciences strategy in the year ahead.

Speakers:
● Caroline Farrell
● Jennifer Everrett
● Tricia Lee
● Tommy Barletta

Discussion Focus

● Reimbursement pathways and payer alignment
● Risk, liability, and insurance considerations for emerging technologies
● Regulatory signals founders and investors must understand
● Using compliance as a strategic advantage rather than a constraint

This conversation will explore what it takes to build and scale healthcare and life sciencescompanies in Washington, DC through accelerator programs, institutional partnerships, andecosystem support.

Speakers:
● Keith Camhi

Discussion Focus

● Reimbursement pathways and payer alignment
● Risk, liability, and insurance considerations for emerging technologies
● Regulatory signals founders and investors must understand
● Using compliance as a strategic advantage rather than a constraint

Participants

● Keith Camhi, Managing Director, Techstars DC
● Jessica Locke, Kaiser Permanente
● Kevin Morgan, Facilitator

Key Themes

● Why DC is uniquely positioned for healthcare innovation
● Lessons from hosting global startup cohorts locally
● How founders can leverage DC’s institutional density

Three curated product demonstrations focused on real-world deployment, operational readiness,and early commercial traction.

NervMyo Therapeuticspresenter: Erica Lee

This panel will focus on how investors, financial institutions, and advisors are approachinghealthcare and life sciences investments amid evolving market conditions.

Speakers:
● Michelle Boquiren Urben (Moderator)
● Bryce Arruda
● Emily Zhen

Discussion Focus
● Deal structures, valuation discipline, and timing
● What investors expect from founders in 2026
● The role of accelerators and strategic capitalAdvisory perspectives on diligence, scale, andexits

-